Manali [MANALIPETC] vs Uniphos Enterprises [UNIENTER] Detailed Stock Comparison
Manali
NSE
Loading...
Uniphos Enterprises
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Manali wins in 12 metrics, Uniphos Enterprises wins in 7 metrics, with 0 ties. Manali appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Manali | Uniphos Enterprises | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.66 | 3,110.20 | Manali |
| Price-to-Book Ratio | 1.02 | 0.38 | Uniphos Enterprises |
| Debt-to-Equity Ratio | 11.80 | 0.00 | Uniphos Enterprises |
| PEG Ratio | 3.98 | 6.91 | Manali |
| EV/EBITDA | 15.73 | -258.74 | Uniphos Enterprises |
| Profit Margin (TTM) | 3.44% | -0.27% | Manali |
| Operating Margin (TTM) | 6.44% | -17.10% | Manali |
| EBITDA Margin (TTM) | 6.44% | N/A | N/A |
| Return on Equity | 2.68% | 0.01% | Manali |
| Return on Assets (TTM) | 2.09% | 0.01% | Manali |
| Free Cash Flow (TTM) | $-1.20B | $-27.17M | Uniphos Enterprises |
| Dividend Yield | 1.07% | 3.78% | Uniphos Enterprises |
| 1-Year Return | -28.48% | -10.16% | Uniphos Enterprises |
| Price-to-Sales Ratio (TTM) | 1.25 | 9.31 | Manali |
| Enterprise Value | $9.22B | $10.09B | Uniphos Enterprises |
| EV/Revenue Ratio | 1.03 | 8.83 | Manali |
| Gross Profit Margin (TTM) | 36.50% | 0.99% | Manali |
| Revenue per Share (TTM) | $52 | $17 | Manali |
| Earnings per Share (Diluted) | $1.77 | $-0.05 | Manali |
| Beta (Stock Volatility) | -0.08 | 0.28 | Manali |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Manali vs Uniphos Enterprises Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Manali | -0.71% | -4.62% | -7.67% | 13.19% | 5.87% | 1.90% |
| Uniphos Enterprises | -0.39% | -0.22% | -4.81% | -6.17% | 5.98% | -4.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Manali | -28.48% | -31.00% | 127.29% | 173.22% | 503.63% | 262.51% |
| Uniphos Enterprises | -10.16% | 15.06% | 127.63% | 297.76% | 353.64% | 361.03% |
Performance & Financial Health Analysis: Manali vs Uniphos Enterprises
| Metric | MANALIPETC | UNIENTER |
|---|---|---|
| Market Information | ||
| Market Cap | ₹11.17B | ₹10.64B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 335,607 | 7,668 |
| 90 Day Avg. Volume | 1,443,788 | 9,695 |
| Last Close | ₹64.43 | ₹152.15 |
| 52 Week Range | ₹49.93 - ₹95.75 | ₹129.44 - ₹195.50 |
| % from 52W High | -32.71% | -22.17% |
| All-Time High | ₹149.65 (Apr 18, 2022) | ₹518.07 (Nov 17, 2003) |
| % from All-Time High | -56.95% | -70.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.94% |
| Quarterly Earnings Growth | 0.10% | 0.94% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.00% |
| Operating Margin (TTM) | 0.06% | -0.17% |
| Return on Equity (TTM) | 0.03% | 0.00% |
| Debt to Equity (MRQ) | 11.80 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹63.78 | ₹400.22 |
| Cash per Share (MRQ) | ₹19.26 | ₹2.42 |
| Operating Cash Flow (TTM) | ₹-671,300,000 | ₹4.31M |
| Levered Free Cash Flow (TTM) | ₹293.10M | ₹2.78M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.07% | 3.78% |
| Last 12-Month Dividend | ₹0.75 | ₹5.70 |
Valuation & Enterprise Metrics Analysis: Manali vs Uniphos Enterprises
| Metric | MANALIPETC | UNIENTER |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.66 | 3,110.20 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 3.98 | 6.91 |
| Price to Sales (TTM) | 1.25 | 9.31 |
| Price to Book (MRQ) | 1.02 | 0.38 |
| Market Capitalization | ||
| Market Capitalization | ₹11.17B | ₹10.64B |
| Enterprise Value | ₹9.22B | ₹10.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.03 | 8.83 |
| Enterprise to EBITDA | 15.73 | -258.74 |
| Risk & Other Metrics | ||
| Beta | -0.08 | 0.28 |
| Book Value per Share (MRQ) | ₹63.78 | ₹400.22 |
Financial Statements Comparison: Manali vs Uniphos Enterprises
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MANALIPETC | UNIENTER |
|---|---|---|
| Revenue/Sales | ₹2.35B | ₹58.58M |
| Cost of Goods Sold | ₹1.49B | ₹58.00M |
| Gross Profit | ₹856.50M | ₹580,000 |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹151.10M | ₹-10.02M |
| EBITDA | ₹308.50M | ₹-8.31M |
| Pre-Tax Income | ₹199.60M | ₹-7.36M |
| Income Tax | ₹56.20M | ₹0 |
| Net Income (Profit) | ₹143.40M | ₹-7.36M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MANALIPETC | UNIENTER |
|---|---|---|
| Cash & Equivalents | ₹1.90B | ₹120.80M |
| Total Current Assets | ₹6.92B | ₹162.63M |
| Total Current Liabilities | ₹2.09B | ₹18.41M |
| Long-Term Debt | ₹940.30M | N/A |
| Total Shareholders Equity | ₹10.94B | ₹27.42B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹3.11B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MANALIPETC | UNIENTER |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MANALIPETC | UNIENTER |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 335,607 | 7,668 |
| Average Daily Volume (90 Day) | 1,443,788 | 9,695 |
| Shares Outstanding | 172.00M | 69.55M |
| Float Shares | 86.02M | 14.57M |
| % Held by Insiders | 0.53% | 0.79% |
| % Held by Institutions | 0.00% | 0.11% |
Dividend Analysis & Yield Comparison: Manali vs Uniphos Enterprises
| Metric | MANALIPETC | UNIENTER |
|---|---|---|
| Last 12-Month Dividend | ₹0.75 | ₹5.70 |
| Last 12-Month Dividend Yield | 1.07% | 3.78% |
| 3-Year Avg Annual Dividend | ₹1.33 | ₹5.95 |
| 3-Year Avg Dividend Yield | 1.54% | 3.85% |
| 3-Year Total Dividends | ₹4.00 | ₹17.85 |
| Ex-Dividend Date | Sep 10, 2024 | Sep 06, 2024 |